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As a result of the strong structural and functional similarities between the innate immune
system of mammals and the insect immune response, insects have been exploited for eval-
uating the virulence of fungal pathogens of humans and for assessing the efficacy of anti-
fungal agents. There is a strong correlation between the results obtained using insects and
mammals and insects have the added advantage of being cheap to purchase, give results in
24e48 h and are without the ethical and legal restrictions associated with the use of
mammals. Larvae of Galleria mellonella are excellent in vivo models and have been used
with a variety of fungi and anti-fungal agents. Factors affecting the use of G. mellonella
larvae are described and examples of where these larvae have been utilized are discussed.
ª 2010 The British Mycological Society. Published by Elsevier Ltd. All rights reserved.1. Insect models for studying microbial the strong structural and functional similarities between the
pathogens of mammals
Conventional in vivo assays to assess the efficacy of anti-
microbial agents or to determine the virulence of fungal path-
ogens or mutants have traditionally relied upon the use of
a variety of vertebrate species. Mice, rats, guinea pigs and
birds have been widely used with a range of fungal pathogens
and although these animals give results that can be directly
applied to humans their cost and the desire to reduce their
use has led to the development of alternative models. Due to9; fax: þ353 1 7083845.
(K. Kavanagh).
ritish Mycological Societimmune response of insects and the innate immune
responses of mammals insects are now being employed to
study alterations in microbial virulence (Kavanagh and
Reeves, 2004; Lionakis and Kontoyiannis, 2005; Fuchs and
Mylonakis, 2006) and the efficacy of novel anti-microbial drugs
(Hamamoto et al., 2004, 2009). A variety of different insects
species have been employed to study microbeehost interac-
tions and include Drosophila melanogaster, Galleria mellonella,
Bombyx mori and Manduca sexta. A wide range of microorgan-
sims have been studied in insects including many bacterialy. Published by Elsevier Ltd. All rights reserved.
Table 1 e Selected examples of utilization of Galleria
larvae with fungi and anti-fungal agents
Yeasts
Cotter et al., 2000 Differentiation of virulence of range
of yeast species
Brennan et al., 2002 Comparison of virulence of C. albicans
mutants with virulence in mice
Vegapuldi et al., 2009 Sexually reproduced spores from
Crypotococcus as effective infectious
propagules
Mylonakis et al., 2005 Development of model for studying
virulence of Cryptococcus
Mylonakis et al., 2005 Assessing the virulence of different
C. neoformans strains in an invertebrate
model
Fan et al., 2007 Analysis of the virulence of Eca 1
mutants of C. neoformans in
G. mellonella
Filamentous fungi
Reeves et al., 2006 Assessment of alteration in pes 1
mutant of A. fumigatus
Vickers et al., 2007 Demonstration of efficacy of
anti-Cts-D antibody in vivo
Wodja et al., 2009 Heat shock and natural infection by
B. bassiana induce an anti-fungal
response
Jackson et al., 2009 Assessment of virulence of melanin
mutants of A. fumigatus
Scully and Bidochka, 2006 Host specialization of A. flavus in
G. mellonella
Fuguet and Vey, 2004 Role of toxins from Beauvaria spp. in an
in vivo model
Fuguet and Vey, 2004 Isolation and characterization of
insecticidal chitinases
Reeves et al., 2004 In vivo analysis of the effect of gliotoxin
as a virulence factor of A. fumigatus
Assessment of anti-fungal activity
Cowen et al., 2009 Identification of Hsp 90 as a drug target
in an in vivo model
Rowan et al., 2009 Evaluation of anti-fungal efficacy of
silver-based compounds
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fungal pathogens (Mylonakis et al., 2005; Reeves et al., 2004;
Cotter et al., 2000).
The insect immune response
The insect immune system demonstrates a number of struc-
tural and functional similarities to the innate immune
response of mammals (Rock et al., 1998; Wittwer et al., 1999;
Zhao and Kanost, 1996). The cuticle of the insect serves a func-
tion analogous to the skin of mammals and provides a barrier
to infection. The haemolymph of insects is contained within
the body cavity (haemocoel) and serves a function comparable
to blood where it transports nutrients, waste products and
signal molecules (Matha and Mracek, 1984). Haemolymph
contains immune cells called haemocytes which are capable
of immobilising and killing invading microbes (Lavine and
Strand, 2002). There are at least six types of haemocytes in
insects and these show similarities to mammalian neutro-
phils in terms of their ability to phagocytose and kill patho-
gens by the generation of superoxide (Bergin et al., 2005;
Renwick et al., 2007). The humoral element of the insect
immune response consists of the processes of melanisation,
haemolymph clotting, anti-microbial peptide synthesis and
wound healing (Kavanagh and Reeves, 2004). Anti-microbial
peptides (AMPs) are released from haemocytes and internal
organs into the haemolymph where they attack components
of the bacterial and fungal cell wall (Ratcliffe, 1985). Since
innate immune response of mammals is a vital component
in the immune response to pathogenic infections (Levy,
2001; Romani, 1999), results obtained using insects show
a strong correlation to those that can be obtained using mice
(Brennan et al., 2002).
Insect models of infection
Insect models of microbial infection have been employed to
investigate the anti-microbial properties of drugs (Lionakis
and Kontoyiannis, 2005; Johny et al., 2007) and offer many
advantages over the use of mammals (Kavanagh and Reeves,
2004). There have also been many reports of the efficacy of
insects in studying the therapeutic effects of antibiotics
(Hamamoto et al., 2004; Alippi et al., 2005) and the anti-microbial
effects of various drugs (Lionakis et al., 2005; Lionakis and
Kontoyiannis, 2005; Tickoo and Russell, 2002). Lionakis and
Kontoyiannis (2005)employedD.melanogasterasa fast, inexpen-
sive high-throughput screening model for anti-Aspergillus
compounds and in investigations of the role of Aspergillus viru-
lence factors in pathogenesis. Although allAspergillus virulence
and therapeutic investigations cannot be performed in these
models they do provide primary testing systems and may
reduce the number of mammals being utilized.
2. The G. mellonella infection model
Recent studies have shown that larvae of the Greater Wax
moth, G. mellonella (Lepidoptera: Pyralidae) may be used as
effective models for studying microbial virulence G. mellonella
larvae are easy to culture and are inexpensive to purchase (seeTable 1). Results can be obtained within 48 h and a large
amount of insects can be inoculated in a short period of
time (Cotter et al., 2000) (see Fig. 1). Larvae of G. mellonella
have been employed to determine the relative virulence
Candida albicans isolates and to differentiate between patho-
genic and non-pathogenic yeast species (Cotter et al., 2000).
A positive correlation between the virulence of C. albicans
mutants when tested in G. mellonella larvae and in BalbC
mice has been established (Brennan et al., 2002) and a number
of factors affecting the virulence of C. albicans mutants in
Galleria larvae have been identified (Dunphy et al., 2003).
G. mellonella larvae have been used to demonstrate a correla-
tion between toxin production and virulence of the pulmo-
nary pathogen Aspergillus fumigatus (Reeves et al., 2004) and
a correlation between the stage ofA. fumigatus spore germina-
tion and virulence has also been established (Renwick et al.,
2006). Earlier work demonstrated the use of Galleria larvae
for investigating the immunosuppressive activities of fungal
secondary metabolites (Gotz et al., 1997), by assessing anti-
Fig. 1 e Living (A) and dead (B) G. mellonella larvae that had been infected with C. albicans.
Galleria mellonella larvae as models 81phagocytic properties and changes in cytoskeletal microtu-
bule formation.
G. mellonella larvae were also employed to establish appro-
priate infectionmodels for Cryptococcus neoformans (Mylonakis
et al., 2005). Invertebrates such as Acanthamoeba castellanii,
Caenorhabditis elegans, Dictyostelium discoidium, D. melanogaster
and G. mellonella have been employed to study the molecular
mechanisms by which C. neoformans interacts with the host
(London et al., 2006) and results revealed that several viru-
lence-related genes previously known to be involved in C. neo-
formansmammalian infections also played a role in virulence
in G. mellonella.
G. mellonella larvae have been employed to evaluate the
anti-fungal activity of amphotericin B, flucytosine and fluco-
nazole following infection with C. neoformans (Mylonakis
et al., 2005) and to evaluate the in vivo anti-fungal properties
of novel silver-based compounds (Rowan et al., 2009). When
using Galleria larvae or other insects for assessing the anti-
microbial properties of compounds it is important to note
that the introduction of the agent into the haemocoel of the
insect also provokes an anti-microbial immune response
which operates in parallel with the anti-fungal activity of
the introduced agent (Rowan et al., 2009). Thus in cases where
larvae are used to determine the anti-microbial properties of
a novel compound it is important to be able to differentiate
between the inherent anti-fungal properties of the agent and
the anti-microbial responses induced by the agent.Fig. 2 e Procedure for inoculating G. mellonella larvae. The
needle is inserted into the last left pro-leg in order to
introduce the pathogen into the insect haemocoel.3. Inoculation of G. mellonella larvae
Whilemany insectmodels are now available for use the larvae
of G. mellonella have many advantages. Due to their size
(1.5e2.5 cm) it is possible to inoculate individual larvae with
specificdoses of thepathogen inquestionwhereas it is difficult
to quantify the dose per insect when using other models such
as Drosophila. In addition G. mellonella larvae can be purchasecommercially and yield results in 24e48 h. Larvae can be incu-
bated at temperature up to 30e37 C but appropriate controls
should be employed as alterations in temperature can prime
the immune response (Mowlds and Kavanagh, 2008).
Larvae of G. mellonella are easy to inoculate via injection
into the haemocoel through the last left pro-leg (Cotter et al.,
2000) (see Fig. 2). The base of the pro-leg can be opened by
applying gentle pressure to the sides of the leg and this aper-
ture will re-seal after removal of the syringe needle without
leaving a scar. Inoculation of larvae with test microorganisms
must be accompanied by inoculation of larvae with the buffer
used to re-suspend the testmicroorganisms (or to dissolve the
test compound) to ensure that this has no impact on larval
viability. A number of workers also suggest the ‘mock-inocu-
lation’ of a number of larvae per experiment to ensure that
the handling and inoculation procedures are not deleterious
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et al., 2000). Larvae can be stored at 15 C prior to use and, once
inoculated, may be maintained at temperatures up to 37 C as
long as appropriate controls are implemented to quantify the
effect of temperature on survival. However the practice of
‘chilling’ larvae by incubation at 4 C prior to inoculation in
order to retard their movement should be avoided as it has
been shown to alter their immune response andmay compro-
mise results (Mowlds and Kavanagh, 2008). Larvae should be
handled with care as rough handling affects survival and
also leads to the expression of stress proteins (Mowlds et al.,
2008).
Inoculated larvae will begin to turn brown/black within
a short period of time depending upon the virulence of the
pathogen (Fig. 1). This is due to the onset of melanisation e
an insect immune response resulting from the cleavage of
prophenoloxidase to active phenoloxidase designed to limit
the growth of the pathogen within the haemocoel. (Kavanagh
and Reeves, 2004). Dead larvae will appear black in colour
however it isworthnoting that somepathogens (e.g.Aspergillus
flavus)may lead to theappearanceofared/brownpigmentation
in the insect cuticle. While larval death is often used as the
endpoint in an experiment other parameters may also be
employed particularly when dealing with a relatively ‘weak’
pathogen or mutant with attenuated virulence which may
not actually kill the test larvae. Fluctuations in fungal load
and haemocyte density have been used as accurate indicators
of fungal virulence in larvae (Bergin et al., 2003) ashavechanges
in the expressionof anti-microbial peptides (Bergin et al., 2006).
When analysing a variety of C. albicans strains in larvae of
G. mellonella isolates of high virulence could be detected by
a decrease in circulating haemocyte density and an increase
in fungal load whereas isolates of low virulence were detect-
able by a high haemocyte density and a low fungal load
(Bergin et al., 2003). Changes in the expression of selected
anti-microbial peptides can be used as an indicator of the
immune response to infection and assist in differentiating
pathogenic from non-pathogenic infections. (Bergin et al.,
2006). Irrespective of which endpoint is used (larval death,
fungal load,haemocytedensity, anti-microbial peptideexpres-
sion, proteomic profile) results can be obtained within 48 h.
While G. mellonella larvae offer many advantages as an
alternative model for studying fungal pathogens of humans
a number of points should be borne in mind regarding the
appropriateness of their use. The larvae are a good model
for studying pathogens that infect systemically through the
bloodstream (e.g. C. albicans, C. neoformans) and in our hands
we have found the strongest correlation with the results
obtained using BalbC mice (Brennan et al., 2002). Larvae do
not possess comparable structures to many of the organs
frequently infected by human fungal pathogens (e.g. lungs,
spleen, brain) and as a consequence cannot be used as amodel
to study dissemination within these organs. However the use
of G. mellonella larvae represents a significant reduction in
time, cost and in the need to usemammalswith the attendant
ethical and legal concerns. Used correctly, andwith the appro-
priate controls, insects (Kavanagh and Reeves, 2004) and
G. mellonella larvae in particular (Mylonakis, 2008), provide
a rapid and effective means of studying fungal virulence and
for assessing the efficacy of anti-microbial drugs.r e f e r e n c e s
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